Cas:180530-15-8 2-Acetamido-5-bromopyrimidine manufacturer & supplier

We serve Chemical Name:2-Acetamido-5-bromopyrimidine CAS:180530-15-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Acetamido-5-bromopyrimidine

Chemical Name:2-Acetamido-5-bromopyrimidine
CAS.NO:180530-15-8
Synonyms:N-(5-bromopyrimidin-2-yl)acetamide
Molecular Formula:C6H6BrN3O
Molecular Weight:216.03500
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:58.37000
Exact Mass:214.96900
LogP:1.84700

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(5-bromopyrimidin-2-yl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(5-bromopyrimidin-2-yl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(5-bromopyrimidin-2-yl)acetamide Use and application,N-(5-bromopyrimidin-2-yl)acetamide technical grade,usp/ep/jp grade.


Related News: Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates. 2-Acetamido-5-bromopyrimidine manufacturer The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 2-Acetamido-5-bromopyrimidine supplier Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. 2-Acetamido-5-bromopyrimidine vendor Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. 2-Acetamido-5-bromopyrimidine factory The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday.